Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MRNA > SEC Filings for MRNA > Form 8-K on 8-Nov-2012All Recent SEC Filings

Show all filings for MARINA BIOTECH, INC.



Termination of a Material Definitive Agreement

Item 1.02 Termination of a Material Definitive Agreement.

On November 2, 2012, Debiopharm S.A. provided notice to Marina Biotech, Inc. ("Marina") that the Research and License Agreement, dated February 3, 2011, between Marina and Debiopharm, would be terminated effective December 5, 2012, due to Debiopharm's own operational reasons. Marina had previously granted to Debiopharm an exclusive license to develop and commercialize Marina's pre-clinical program in bladder cancer, for all uses in humans and animals for the prevention and treatment of superficial (non-muscle invasive) bladder cancer, in consideration of certain milestone and royalty payments. Following the termination of the license agreement, Marina's bladder cancer program will be returned to us without any obligations beyond those minor activities associated with the termination period and will be reincorporated into Marina's internal preclinical pipeline with the intention of advancing the program once either appropriate funding or a new partner is obtained.

  Add MRNA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MRNA - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.